Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1245885.RAC6RtxnLGD79-RZE6gpjoa0YK7LZJE6MzAdCJnwtmfY4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1245885.RAC6RtxnLGD79-RZE6gpjoa0YK7LZJE6MzAdCJnwtmfY4130_assertion type Assertion NP1245885.RAC6RtxnLGD79-RZE6gpjoa0YK7LZJE6MzAdCJnwtmfY4130_head.
- NP1245885.RAC6RtxnLGD79-RZE6gpjoa0YK7LZJE6MzAdCJnwtmfY4130_assertion description "[Most notable associations were for hsa-miR-145-3p [hazard ratio (HR) 2.94, 95% confidence interval (CI) 1.54, 5.61], and hsa-miR-9-3p (HR 10.28, 95% CI 1.31, 80.84) with colon cancer and hsa-miR-335-5p (HR 0.17, 95% CI 0.05, 0.54) for rectal cancer. hsa-miR-374a-5p, hsa-miR-570-3p and hsa-miR-18a-5p significantly reduced the hazard of dying for all cases, regardless of tumor site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245885.RAC6RtxnLGD79-RZE6gpjoa0YK7LZJE6MzAdCJnwtmfY4130_provenance.
- NP1245885.RAC6RtxnLGD79-RZE6gpjoa0YK7LZJE6MzAdCJnwtmfY4130_assertion evidence source_evidence_literature NP1245885.RAC6RtxnLGD79-RZE6gpjoa0YK7LZJE6MzAdCJnwtmfY4130_provenance.
- NP1245885.RAC6RtxnLGD79-RZE6gpjoa0YK7LZJE6MzAdCJnwtmfY4130_assertion SIO_000772 25484364 NP1245885.RAC6RtxnLGD79-RZE6gpjoa0YK7LZJE6MzAdCJnwtmfY4130_provenance.
- NP1245885.RAC6RtxnLGD79-RZE6gpjoa0YK7LZJE6MzAdCJnwtmfY4130_assertion wasDerivedFrom befree-2016 NP1245885.RAC6RtxnLGD79-RZE6gpjoa0YK7LZJE6MzAdCJnwtmfY4130_provenance.
- NP1245885.RAC6RtxnLGD79-RZE6gpjoa0YK7LZJE6MzAdCJnwtmfY4130_assertion wasGeneratedBy ECO_0000203 NP1245885.RAC6RtxnLGD79-RZE6gpjoa0YK7LZJE6MzAdCJnwtmfY4130_provenance.